Cancer touches each and every one of us in one way or another. So we are all affected by how cancer is treated and studied.
- Is Finland currently a model country for personalised cancer care – and what about the future?
- Does it matter to patients whether Finland has state-of-the-art cancer research?
- And what can we expect in the future from precision cancer medicine based on increasingly accurate genetic information?
Update your knowledge on the current status, challenges and future of personalised cancer care and cancer research. We will delve into current issues with experts and cancer survivors at the University of Helsinki’s Science Corner on Wednesday 8 September from 17-18.30.
The event will be hosted by Baba Lybeck and will be discussed by:
- Anniina Färkkilä, Associate Professor, Specialist in Gynaecology and Obstetrics, University of Helsinki and HUS
- Tapio Visakorpi, Professor, Dean, Faculty of Medicine and Health Technology, University of Tampere, Finland
- Tuula Helander, Director, Biotechnology and Pharmaceuticals Unit, Ministry of Social Affairs and Health
- Laura Saarelainen, rare cancer survivor
Also present with video presentations are:
- Jussi Koivunen, Cancer Specialist, Associate Professor, PPSHP, FICAN North
- Tomi Mäkelä, Professor, iCAN, University of Helsinki and HUS
- Bettina Ryll, Melanoma Patient Network Europe, Founder; EU Cancer Action, Member of the Steering Committee
- Marikki Laiho, Professor, Johns Hopkins University
The event will be streamed and you can follow it on the Science Corner website. A recording of the event will be shared on this page at a later date. The Science Corner is closed to the public due to the corona situation.
You can also contribute to the programme by sending questions to the speakers, either before or during the event. The event is free of charge, open to all and part of the Year of Science 2021.
The event is organised in cooperation with Finnish Cancer Patients, Helsinki Biobank, the Finnish Cancer Institute Foundation and iCAN, the flagship of digital personalised cancer research at the University of Helsinki and HUS. The event is also supported by the Finnish Cancer Institute Foundation and the Finnish Cancer Patients Association’s Model Country for Individualised Cancer Care project, which is supported by six pharmaceutical companies: AstraZeneca, Bristol-Myers Squibb, MSD, Pfizer, Roche and Takeda.
Welcome to join us!